Interpersonal Psychotherapy for Depression After Perinatal Loss
(HeAL Trial)
Trial Summary
What is the purpose of this trial?
This study tests the efficacy of interpersonal psychotherapy (IPT) for major depression following perinatal loss (early and late fetal death and early neonatal death) in a sample of 274 women in Flint and Detroit, Michigan. The trial will be the first fully powered randomized trial of treatment for any psychiatric disorder following perinatal loss.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must have a stable course of antidepressant medication, meaning no changes in the dose for at least 12 weeks before joining the study.
What data supports the effectiveness of the treatment Interpersonal Psychotherapy for Depression After Perinatal Loss?
Research shows that Interpersonal Psychotherapy (IPT) is effective in reducing depressive symptoms and improving social support and grief symptoms in women who have experienced perinatal loss. It has also been successful in treating depression related to other types of loss, such as the loss of a spouse, and in postpartum depression, indicating its potential effectiveness for perinatal loss-related depression.12345
Is interpersonal psychotherapy (IPT) safe for humans?
How is the treatment Interpersonal Psychotherapy (IPT) for depression after perinatal loss different from other treatments?
Interpersonal Psychotherapy (IPT) for depression after perinatal loss is unique because it specifically addresses the social and emotional challenges following perinatal loss, such as grief and the need for social support, which are not the primary focus of other treatments like cognitive behavioral therapy. This therapy is delivered in a group setting, which can enhance social support, and has shown higher satisfaction and effectiveness in reducing depressive symptoms compared to other treatments.12347
Research Team
Jennifer E Johnson, PhD
Principal Investigator
Michigan State University
Eligibility Criteria
This trial is for women aged 18-50 in Flint and Detroit, Michigan who have experienced perinatal loss within the last year and are now facing major depression. Participants must speak English, be able to provide contacts for follow-up, have telephone access, and meet specific mental health criteria without recent psychotherapy or unstable medication use.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 12 group sessions and 2 individual sessions of interpersonal psychotherapy (IPT) for major depression following perinatal loss
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 8, 16, and 28 weeks
Open-label extension (optional)
Participants may opt into continuation of treatment long-term
Treatment Details
Interventions
- Coping with Depression
- Interpersonal psychotherapy for major depression following perinatal loss
Find a Clinic Near You
Who Is Running the Clinical Trial?
Michigan State University
Lead Sponsor
Women and Infants Hospital of Rhode Island
Collaborator